0Suppliers
0Customers
1Debt Items
20Related Chains

Adlai Nortye Ltd. Suppliers

No suppliers on recordAdlai Nortye Ltd. has not yet been matched to upstream suppliers in our database, or is still being processed.

Adlai Nortye Ltd. Customers

No clients on recordNo downstream customers found in our database for Adlai Nortye Ltd..

Adlai Nortye Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ANL-DEBT Debt stack $26.4M 90% Market cache reports total debt of $26.4M.

Adlai Nortye Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Adlai Nortye Ltd..

Adlai Nortye Ltd. Ownership

HolderNameConfidenceEvidence
ANL-OWNER-VENROCK-ADVISER-LLC Venrock Adviser, LLC 90% 13F overlay lists Venrock Adviser, LLC as top holder; 27 tracked holders.

Adlai Nortye Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EDIT Editas Medicine, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
BEAM Beam Therapeutics Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BBIO BridgeBio Pharma, Inc. 100.00 2